Cargando…
An Analysis of the Neuropathic Pain Components in Rheumatoid Arthritis Patients
OBJECTIVE: To analyze the neuropathic pain (NeP) components in patients with rheumatoid arthritis (RA). METHODS: The painDETECT questionnaire (PD-Q) was completed by 300 RA patients (79 men, 221 women). RESULTS: Nine patients (3.0%) were categorized as likely NeP, 33 (11.0%) were categorized as poss...
Autores principales: | Ito, Satoshi, Kobayashi, Daisuke, Murasawa, Akira, Narita, Ichiei, Nakazono, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849541/ https://www.ncbi.nlm.nih.gov/pubmed/29225253 http://dx.doi.org/10.2169/internalmedicine.9235-17 |
Ejemplares similares
-
Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis
por: Kobayashi, Tetsuo, et al.
Publicado: (2016) -
Interleukin‐6 receptor inhibitor tocilizumab ameliorates periodontal inflammation in patients with rheumatoid arthritis and periodontitis as well as tumor necrosis factor inhibitors
por: Kobayashi, Tetsuo, et al.
Publicado: (2015) -
The Efficacy of Biological Disease-modifying Antirheumatic Drugs on Sarcopenia in Patients with Rheumatoid Arthritis
por: Hasegawa, Eriko, et al.
Publicado: (2023) -
Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report
por: Sato, Hiroe, et al.
Publicado: (2014) -
Effectiveness and Safety of Golimumab for Patients ≥75 Years Old with Rheumatoid Arthritis
por: Kurosawa, Yoichi, et al.
Publicado: (2022)